Arevalo, J.F., et al.,
Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan American Collaborative Retina Study Group at 6-month follow-up.
Ophthalmology, 2007. 114(4): p. 743-50.

Bansal, A.G., et al.
Neovascular changes after pegaptanib in diabetics.
Ophthalmology, 2007. 114(3): p. 615-6, 2007. 21(2): p. 238-45.

Bhavsar, A.R., M.S. Ip, and A.R. Glassman
The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials.
Am J Ophthalmol, 2007. 144(3): p. 454-6.

Chew, E., et al.,
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.
Ophthalmology, 2007. 114(6): p. 1190-6.

Chu, Y.K., et al.
Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
Eye, 2007. april : p1-5

Fong, D.S., et al. (Writing Committee for the Diabetic Retinopathy Clinical Research Network)
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
Arch Ophthalmol, 2007. 125(4): p. 469-80.

Gibran, S.K.K., K. Jungkim, S. Cleary, P. E.,
Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular oedema.
Ophthalmology, 2007. 114(5): p. 890-4.

Gillies, M.C., et al.
Efficacy and Safety of Multiple Intravitreal Triamcinolone Injections for Refractory Diabetic Macular Oedema.
Br J Ophthalmol, 2007.

Hitani, K.Y., T. Sato, Y.,
Long-term results of grid pattern photocoagulation for diffuse diabetic macular edema.
Nippon Ganka Gakkai Zasshi, 2007. 111(5): p. 401-6.

Iida, T.
Combined triamcinolone acetonide injection and grid laser photocoagulation: a promising treatment for diffuse diabetic macular oedema?
Br J Ophthalmol, 2007. 91(4): p. 407-8.

Kayykcyolu, O., et al.
Macular Edema in Unregulated Type 2 Diabetic Patients Following Glycemic Control.
Arch Med Res, 2007. 38(4): p. 398-402.

Kroll, P., E.B. Rodrigues, and S. Hoerle
Pathogenesis and classification of proliferative diabetic vitreoretinopathy.
Ophthalmologica, 2007. 221(2): p. 78-94.

Lam, D.S., et al.
A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.
Br J Ophthalmol, 2007. 91(2): p. 199-203

Lang Y, et al.
Evaluation of intravitreal kenalog toxicity in humans.
Ophthalmology. 2007 Apr;114(4):724-31. E

Neubauer, A.S., et al.
Topography of diabetic macular oedema compared with fluorescein angiography.
Acta Ophthalmol Scand, 2007. 85(1): p. 32-9.

Olafsdottir, E., D.K. Andersson, and E. Stefansson
Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease.
Acta Ophthalmol Scand, 2007. 85(1): p. 40-5.

Otani, T. and S. Kishi
Correlation between optical coherence tomography and fluorescein angiography findings in diabetic macular edema.
Ophthalmology, 2007. 114(1): p. 104-7.

The PKC-DMES Study Group
Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial.
Arch Ophthalmol, 2007. 125(3): p. 318-24

REJ Ryder, T.M., BL Swain, F Tabbassam, W Illahi
Red dots near the centre of the fovea on digital retinal photographs in diabetic retinopathy screening
practical diabetes int, 2007. 24(2): p. 79-84.

Sachdev, N., et al.
Correlation between microaneurysm closure rate and reduction in macular thickness following laser photocoagulation of diabetic macular edema.
Eye, 2007.

Sandhu, S.S., et al.
Short-term effects of focal argon laser treatment in diabetic maculopathy as demonstrated by optical coherence tomography.
Retina, 2007. 27(1): p. 13-20

Schiff, W.M., et al.
Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes.
Ophthalmology, 2007. 114(3): p. 544-50.

Shimura, M.
Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes
J Ocul Pharmacol Ther, 2007. 23(3): p. 284-291

Shimura, M.
Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema.
Br J Ophthalmol. 2007 Apr;91(4):449-54.

Vinten, M., et al.
Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
Acta Ophthalmol Scand, 2007. 85(1): p. 21-6.

Writing Committee for the Diabetic Retinopathy Clinical Research Network
Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
Arch Ophthalmol, 2007. 125(4): p. 469-80

Yamashita, T., et al.,
Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
J Glaucoma, 2007. 16(2): p. 220-4.

Yang CM, Yeh PT, Yang CH.
Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
Ophthalmology. 2007 Apr;114(4):710-5.

Yanyali A, Aytug B, Horozoglu F, Nohutcu AF.
Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes.
Am J Ophthalmol. 2007 Jul;144(1):124-6.